| pubmed-article:8455811 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8455811 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
| pubmed-article:8455811 | lifeskim:mentions | umls-concept:C0020971 | lld:lifeskim |
| pubmed-article:8455811 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:8455811 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:8455811 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8455811 | pubmed:dateCreated | 1993-4-22 | lld:pubmed |
| pubmed-article:8455811 | pubmed:abstractText | Rates of hepatitis B infection have remained high despite immunization programs for infants of HBsAg-positive mothers and individuals considered to be at high risk for exposure. The Centers for Disease Control and Prevention and the American Academy of Pediatrics have provided new recommendations for a comprehensive strategy to eliminate hepatitis B virus. The first priority is the prenatal screening of all pregnant women and follow-up vaccination of all infants. The second is the immunization of at-risk adolescents and adults. Ultimately, it is hoped that all adolescents will be immunized when feasible and that the incidence of hepatitis B virus infection will decline. Primary care providers have an important role in the provision of public education about hepatitis B and in the implementation of these new recommendations. | lld:pubmed |
| pubmed-article:8455811 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8455811 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8455811 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8455811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8455811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8455811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8455811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8455811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8455811 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8455811 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8455811 | pubmed:issn | 0361-1817 | lld:pubmed |
| pubmed-article:8455811 | pubmed:author | pubmed-author:ReeceS MSM | lld:pubmed |
| pubmed-article:8455811 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8455811 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:8455811 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8455811 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8455811 | pubmed:pagination | 42-5, 49-50 | lld:pubmed |
| pubmed-article:8455811 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:meshHeading | pubmed-meshheading:8455811-... | lld:pubmed |
| pubmed-article:8455811 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8455811 | pubmed:articleTitle | Immunization strategies for the elimination of hepatitis B. | lld:pubmed |
| pubmed-article:8455811 | pubmed:affiliation | Family and Community Health, Graduate Nursing Program, University of Massachusetts, Lowell. | lld:pubmed |
| pubmed-article:8455811 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8455811 | pubmed:publicationType | Review | lld:pubmed |
